SCHEMBL24026175

SCHEMBL24026175

Oc1ccc2c3cc4sc5ccccc5c4cc3n(-c3ccccn3)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.37
▸ MAPT P10636 6/20 0.35
▸ ALDH1A1 P00352 6/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ HSD17B10 Q99714 3/20 0.34
▸ MAT2A P31153 2/20 0.34
▸ BCHE P06276 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ BACE1 P56817 1/20 0.33
▸ GPR3 P46089 1/20 0.33
▸ GAA P10253 3/20 0.33
▸ POLB P06746 3/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ MCL1 Q07820 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ NLRP3 Q96P20 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24026092 0.95 MAT2A (0.36) KMT2AMAPTALDH1A1RAB9AHPGD
SCHEMBL17228887 0.89 KMT2A (0.38) KMT2AMAPTALDH1A1RAB9AHPGD
SCHEMBL17071012 0.85 KMT2A (0.36) KMT2AMAPTALDH1A1RAB9AHPGD
SCHEMBL17246581 0.84 KMT2A (0.37) KMT2AMAPTALDH1A1RAB9AHPGD
SCHEMBL17246476 0.84 GPR3 (0.38) KMT2AMAPTALDH1A1RAB9AHPGD
SCHEMBL24026098 0.82 ESR2 (0.39) KMT2AMAPTALDH1A1RAB9AHSD17B10
SCHEMBL15063380 0.82 MAT2A (0.40) KMT2AMAPTALDH1A1RAB9AHPGD
SCHEMBL29992464 0.82 MAT2A (0.40) KMT2AMAPTALDH1A1RAB9AHPGD
SCHEMBL24026135 0.81 ESR2 (0.36) KMT2AMAPTALDH1A1RAB9AHSD17B10
SCHEMBL21328047 0.81 MAT2A (0.35) KMT2AMAPTALDH1A1RAB9AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210359224-A1 TETRADENTATE PLATINUM AND PALLADIUM COMPLEXES BASED ON BISCARBAZOLE AND ANALOGUES UNIV ARIZONA STATE (US) 2021-11-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210359224-A1 TETRADENTATE PLATINUM AND PALLADIUM COMPLEXES BASED ON BISCARBAZOLE AND ANALOGUES PDCD2L, PDCD1, PDCD4 KMT2A 2798/4885MAPT 425/4885ALDH1A1 2784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback